Tendon & Ligament
BPC-157 accelerates tendon healing while TB-500 enhances cell migration to the injury site for coordinated soft tissue repair.
Chang et al. 2014≥99% Purity
BPC-157 / TB-500
A recovery stack studied for faster tissue repair and healing
$115.00$57.50/vial with BOGO
USA madecGMP facility
QuantityBuy 1 Get 1 Free · auto-appliedAdd 2+ items to cart to activate the discount
Free shipping over $200
PASSEDSterility & Endotoxins
PASSEDNet Content & Purity
Researchers also added
Authenticity
Every vial is QR-authenticated
Scan the QR code on any vial to verify its batch, COA, and origin in seconds. Secure traceability from our lab to your bench.
About this compound
A popular recovery stack pairing BPC-157 with TB-500 — two peptides researched together for accelerating tissue repair, healing tendons and muscle, and speeding recovery from injury.
Dual-peptide blend: BPC-157 (15-aa pentadecapeptide) + TB-500 (43-aa active fragment of Thymosin Beta-4)
- Form
- Lyophilized powder blend
0
Synergistic Pathways
VEGF + Actin regulation
0+
Combined Studies
BPC-157 (200+) + TB-500 (170+)
0%
Faster Healing
TB-500 re-epithelialization
0
Research Areas
Tendon & Ligament · Wound Healing · Vascular Repair & more
How It Works
How BPC-157 / TB-500 works
The pathways BPC-157 / TB-500 acts on — and what each one does. The animation traces its signal outward from the compound to every target it engages.
Signalling pathways studied in preclinical models · illustrative
Angiogenesis & Cytoprotection
BPC-157
BPC-157 upregulates VEGF expression and promotes new blood vessel formation, delivering nutrients and oxygen to damaged tissue. It also activates the NO system and demonstrates broad cytoprotective properties.
- VEGF-mediated angiogenesis
- Nitric oxide system modulation
- Gastric and tissue cytoprotection
Cell Migration & Actin Regulation
TB-500
TB-500 sequesters G-actin monomers and promotes cytoskeletal remodeling, enabling repair cells to migrate to injury sites. It also activates integrin-linked kinase (ILK) for tissue repair signaling.
- Actin-mediated cell migration
- Integrin-linked kinase activation
- Anti-fibrotic remodeling
Complementary Repair Cascade
Synergy
BPC-157 initiates vascular support (blood flow to injury), while TB-500 mobilizes repair cells to the site. Together they address two distinct phases of tissue repair — perfusion and cellular migration.
- Phase 1: Blood flow restoration (BPC-157)
- Phase 2: Cell mobilization (TB-500)
- Combined anti-inflammatory effects
Uses & Applications
What BPC-157 / TB-500 is researched for
The main areas BPC-157 / TB-500 is being studied for — and the study-reported figures behind them.
Wound Healing
TB-500 promotes dermal healing and reduces scarring; BPC-157 provides vascular support for nutrient delivery to wound sites.
Malinda et al. 2007Vascular Repair
BPC-157 promotes angiogenesis via the NO system while TB-500 supports cardiac cell migration through ILK activation.
Sikiric et al. 2019Inflammation Control
Both peptides demonstrate anti-inflammatory properties through distinct mechanisms, creating a more controlled healing environment.
Sikiric et al. 2011Molecular Structure
The BPC-157 / TB-500 molecule
An interactive 3D model rendered from the compound record — rotate and explore its structure.
Molecular model
Third-Party Verified
Independently tested. Verifiably pure.
Every batch of BPC-157 / TB-500 is sent to an accredited independent laboratory before it ships. Here is what we screen for.
- HPLC Purity AnalysisConfirms the peptide is ≥99% pure
- Mass SpectrometryVerifies the exact molecular identity
- Heavy Metals ScreeningLead, arsenic, cadmium & mercury — Pass
- Endotoxins (LAL)Bacterial endotoxin levels — Pass
- Sterility TestingNo microbial contamination — Pass
- Net Peptide ContentActual peptide mass per vial verified
Certificate of Analysis · Freedom DiagnosticPASS
- HPLC Purity
- ≥99%
- Identity
- Mass-spec confirmed
- Endotoxin (LAL)
- Pass
- Net content
- Verified
Compound Information
Full specification
| Components | BPC-157 + TB-500 (Thymosin Beta-4) |
| BPC-157 Sequence | 15 amino acids (Gly-Glu-Pro-Pro-Pro...) |
| TB-500 Fragment | 43-amino acid active region of Tβ4 |
| Form | Lyophilized powder blend |
| Purity | ≥99% per component (HPLC verified) |
| Testing | Third-party HPLC, Mass Spec, Endotoxin |
| Storage (Lyophilized) | -20°C for long-term stability |
| Storage (Reconstituted) | 2–8°C, use within 14-21 days |
| Solubility | Bacteriostatic water for reconstitution |
| COA | Included with every order |
| Strength | 20mg |
| Purity (HPLC) | >99% (HPLC) |
| Appearance | White to off-white powder |
| Stability | 24 months from manufacture date when stored properly |
FAQ
Common questions about BPC-157 / TB-500
BPC-157 and TB-500 target complementary repair mechanisms. BPC-157 promotes blood vessel formation (angiogenesis) to deliver nutrients to injured tissue, while TB-500 mobilizes repair cells through actin regulation. Together they address both vascular support and cellular migration phases of tissue repair.
No. The combination has not been studied as a single formulation in clinical trials. The synergy rationale is based on complementary mechanisms from individual component research (200+ BPC-157 studies, 170+ TB-500 studies). Both are well-studied individually in preclinical models.
No. Neither BPC-157 nor TB-500 is FDA approved for any indication. This blend is sold exclusively for in vitro laboratory research purposes and is not intended for human consumption.
Store lyophilized at -20°C for long-term stability. After reconstitution with bacteriostatic water, refrigerate at 2-8°C and use within 14-21 days. Both components maintain stability under standard peptide storage conditions.
Each component undergoes independent third-party testing including HPLC for purity verification, mass spectrometry for molecular weight confirmation, and endotoxin testing. A Certificate of Analysis is included with every order.
Published Literature
Cited Sources
Peer-reviewed literature
Independent published research indexed from PubMed and peer-reviewed journals — not Eon Peptides claims.
[1]
PubMed
[2]Stable gastric pentadecapeptide BPC 157: Novel therapy in gastrointestinal tract
View source PubMed
[3]Thymosin beta 4 activates integrin-linked kinase and promotes cardiac cell migration
View source PubMed
[4]BPC 157 and NO system
View source PubMed
Thymosin beta-4 promotes dermal healing
View source For Research Use Only.
Not for human or veterinary use. For in-vitro laboratory research only. These statements have not been evaluated by the FDA; this product is not intended to diagnose, treat, cure, or prevent any disease. Sold exclusively to qualified researchers and institutions.